Mechanisms of a phosphorothioate oligonucleotide delivery by skin electroporation

International Journal of Pharmaceutics

Volumn 184, Issue 2, 1999, Pages 147-156

  Regnier, V ^a   De Morre, N ^a   Jadoul, A ^a   Preat V ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Electroporation; Mechanisms; Oligonucleotides; Skin; Topical delivery; Transdermal delivery

Indexed keywords

OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG TRANSPORT; ELECTROOSMOSIS; ELECTROPORATION; IONTOPHORESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN ABSORPTION; SKIN PENETRATION; STRATUM CORNEUM;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; ELECTRIC STIMULATION; ELECTROPORATION; IONTOPHORESIS; MALE; OLIGONUCLEOTIDES; RATS; RATS, NUDE; SKIN ABSORPTION;

EID: 0033017924     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00085-4     Document Type: Article

References (37)

1. Bazile D., Mir L., Paoletti C. Voltage dependant introduction of a d[α]octothymidilate into electropermeabilized cells. Biochem. Biophys. Res. Commun. 159:1989;633-639.
2. Belehradek J. Jr., Orlowski S., Ramirez L.H., Pron G., Poddevin B., Mir L.M. Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim. Biophys. Acta. 1190:1994;155-163.
3. Bergan R., Connell Y., Fahmy B., Neckers L. Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy. Nucleic Acids Res. 21:1993;3567-3573.
4. Brand R., Iversen P. Iontophoretic delivery of a telomeric oligonucleotide. Pharm. Res. 13:1996;851-854.
5. Crooke S., Bennett C.F. Progress in antisense oligonucleotide therapeutic. Annu. Pharmacol. Toxicol. 36:1996;107-129.
6. Graham M.J., Freier S.M., Crooke R.M., Eckler D.J., Maslova R.N., Lesnik E.A. Tritium labelling of antisense oligonucleotides by exchange with tritiated water. Nucleic Acids Res. 21:1993;3737-3743.
7. Greenhalgh D.A., Rothnagel J.A., Roop D.R. Epidermis: an attractive target tissue for gene therapy. J. Invest. Dermatol. 103:1994;S63-S69.
8. Guy R. Iontophoresis. Adv. Drug Deliv. Rev. 9:1992;119-317.
9. Jadoul, A., 1997. Skin Perturbations Induced by Iontophoresis and Electroporations: Enhancement in Drug Transport and Integrity of the Stratum Corneum, Ph.D thesis. Université catholique de Louvain, Brussels, Belgium.
10. Klenchin V., Sukharev S., Serov S., Chernomordik L., Chizmadzhev Y. Electrically induced DNA uptake by cells is a fast process involving DNA electrophoresis. Biophys. J. 60:1991;804-811.
11. Nolen H.W. III, Catz P., Friend D.R. Percutaneous penetration of methyl phosphonate antisense oligonucleotides. Int. J. Pharm. 107:1994;169-177.
12. Oldenburgh K.R., Vo K.T., Smith G.A., Selick H.E. Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin. J. Pharm. Sci. 84:1995;915-921.
13. Pliquett U., Weaver J.C. Electroporation of human skin: simultaneous measurement of changes in the transport of two fluorescent molecules and in the passive electrical properties. Bioelectrochem. Bioenerg. 39:1996;1-12.
14. Pliquett U., Zewert T., Chen T., Weaver R., Weaver J. Imaging of fluorescent molecules and small ions transport through human stratum corneum during high voltage pulsing: localized transport regions are involved. Biophys. Chem. 58:1996;185-204.
15. Prausnitz M., Becky S., Milano C., Steward C., Langer R., Weaver J. A quantitative study of electroporation showing a plateau in net molecular transport. Biophys. J. 65:1993;414-422.
16. Prausnitz M.R., Bose V., Langer R., Weaver J.C. Electroporation of mammalian skin to enhance transdermal drug delivery. Proc. Natl. Acad. Sci. USA. 90:1993;10504-10508.
17. Prausnitz M.R., Edelman E.R., Gimm J.A., Langer R., Weaver J.C. Transdermal delivery of heparin by skin electroporation. Bio-Technology. 13:1995;1205-1209.
18. Prausnitz M., Lee C., Liu C., Pang J., Singh T., Langer R., Weaver J.C. Transdermal transport efficiency during skin electroporation and iontophoresis. J. Control. Release. 38:1996;205-217.
19. Prausnitz M., Gimm J., Guy R., Langer R., Weaver J., Cullander C. Imaging of transport pathways across human stratum corneum during high-voltage and low-voltage electrical exposures. J. Pharm. Sci. 85:1996;1363-1370.
20. Regnier V., Le Doan T., Laurent M., Préat V. Cutaneous delivery of oligonucleotides by electroporation. Pharm. Res. 13:1996;S-383.
21. Regnier, V., Le Doan, T., Préat, V., 1998. Parameters controlling topical delivery of oligonucleotides by electroporation. J. Drug Target.
22. Regnier V., Préat V., accepted. Localization of a FITC-labelled phosphorothioate oligonucleotide in the skin after topical delivery by iontophoresis or electroporation. Pharm. Res.
23. Roizman, B., 1992. Inhibition of Herpes Viridae Infection by Antisense Oligonucleotides. PCT WO 92/03051.
24. Rojanasakul Y. Antisense oligonucleotide therapeutics: drug delivery and targeting. Adv. Drug Deliv. Rev. 18:1996;115-131.
25. Shah V.P., Behl C.R., Flynn G.L., Higushi W.I., Scaeffer H. Principles and criteria in the development and optimization of topical therapeutic products. Int. J. Pharm. 82:1992;21-28.
26. Titomirov A.V., Sukharev S., Kistanova E. In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim. Biophys. Acta. 1088:1991;131-134.
27. Vanbever, R., 1997. Skin Electroporation for Transdermal Drug Delivery, Ph.D thesis. Université catholique de Louvain, Brussels, Belgium.
28. Vanbever R., Préat V. Factors affecting transdermal delivery of metoprolol by electroporation. Bioelectrochem. Bioenerget. 38:1995;223-228.
29. Vanbever R., Lecouturier N., Préat V. Transdermal delivery of metoprolol by electroporation. Pharm. Res. 11:1994;1657-1662.
30. Vanbever R., Le Boulangé E., Préat V. Transdermal delivery of fentanyl by electroporation I. Influence of electrical factors. Pharm. Res. 13:1996;557-563.
31. Vanbever R., De Morre N., Préat V. Transdermal delivery of fentanyl by electroporation I. Mechanisms involved in drug transport. Pharm. Res. 13:1996;1360-1366.
32. Vanbever, R., Leroy, M.-A., Préat, V., 1997a. Transdermal permeation of neutral molecules by electroporation. J. Control. Release, in press.
33. Vanbever R., Prausnitz M., Préat V. Macromolecules as novel transdermal transport enhancers for skin electroporation. Pharm. Res. 14:1997;639-644.
34. Vlassov V., Nechaeva M., Karamyshev V., Yakubov L. Iontophoretic delivery of oligonucleotide derivatives into mouse tumor. Antisense Res. Dev. 4:1994;291-293.
35. Weaver J. Electroporation theory. Concepts and mechanisms. Methods Mol. Biol. 47:1995;1-26.
36. Zewert T.E., Pliquett U.F., Langer R., Weaver J.C. Transdermal transport of DNA antisense oligonucleotides by electroporation. Biochem. Biophys. Res. Commun. 212:1995;286-292.
37. Zhang L., Li L., Hoffmann G.A., Hoffman R.M. Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: an approach to gene therapy of skin aging and other diseases. Biochem. Biophys. Res. Commun. 220:1996;633-636.